Skip to main content
Premium Trial:

Request an Annual Quote

Genomic Solutions Introduces Mouse, Rat Microarrays

NEW YORK, Dec 14 - Genomic Solutions has added mouse, rat, and rat p450 microarrays to its GeneMap pre-printed microarray product line, the company said Thursday.

These products are available now under a special early access agreement and will become generally available for sale in January 2001. The company said it could also produce custom microarrays once researchers have identified a specific subset of genes they wish to use for their experiments.

Genomic solutions developed the arrays under an agreement that provides it access to Research Genetics’ library of cDNA.

The mouse and rat arrays each contain 1,700 genes, and the oligonucleotide-based p450 rat arrays contain 300 genes. Genomic solutions plans to market the p450 array as an inexpensive alternative to early drug discovery assays currently performed using protein enzymes. Genomic solutions also plans to offer additional arrays for most of the 5,000 mouse and 17,500 rat genes in Research Genetics’ libraries.

" Our expanded GeneMAP offerings of mouse and rat cDNA arrays are designed to help 'jump start' researchers' microarray experiments," Shannon Richey, vice president of the genomic business unit at Genomic Solutions, said in a statement.

GeneMAP forms part of Genomic Solutions’ GeneTac biochip system, which provides gene expression analysis and DNA library management as well as microarray production, imaging, and analysis.
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.